These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31705285)

  • 1. Psychometric validation of the Breast Cancer Treatment Outcome Scale (BCTOS-12): a prospective cohort study.
    Feißt M; Heil J; Stolpner I; von Au A; Domschke C; Sohn C; Kieser M; Rauch G; Hennigs A
    Arch Gynecol Obstet; 2019 Dec; 300(6):1679-1686. PubMed ID: 31705285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12).
    Hennigs A; Heil J; Wagner A; Rath M; Moosbrugger H; Kelava A; Golatta M; Hug S; Riedel F; Rauch G; Feißt M
    Breast; 2018 Apr; 38():58-65. PubMed ID: 29248875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).
    Heil J; Holl S; Golatta M; Rauch G; Rom J; Marmé F; Gebauer G; Sohn C
    Breast; 2010 Dec; 19(6):470-4. PubMed ID: 20627726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version.
    Brandini da Silva FC; José da Silva J; Sarri AJ; Paiva CE; Aloisio da Costa Vieira R
    Clin Breast Cancer; 2019 Feb; 19(1):e85-e100. PubMed ID: 30473244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and psychometric evaluation of a Dutch-translated shorter Breast Cancer Treatment Outcome Scale (Dutch BCTOS-13).
    Struik GM; de Jongh FW; Birnie E; Pignol JP; Klem TM
    J Patient Rep Outcomes; 2018 Dec; 2(1):60. PubMed ID: 30543030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module.
    Stolpner I; Heil J; Feißt M; Karsten MM; Weber WP; Blohmer JU; Forster T; Golatta M; Schütz F; Sohn C; Hennigs A
    Ann Surg Oncol; 2019 Sep; 26(9):2759-2767. PubMed ID: 31115853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study.
    Pukancsik D; Kelemen P; Újhelyi M; Kovács E; Udvarhelyi N; Mészáros N; Kenessey I; Kovács T; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Feb; 43(2):303-310. PubMed ID: 28069398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining scores based on patient reported outcomes - statistical and medical perspectives.
    Feißt M; Hennigs A; Heil J; Moosbrugger H; Kelava A; Stolpner I; Kieser M; Rauch G
    BMC Med Res Methodol; 2019 Jul; 19(1):167. PubMed ID: 31366326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
    Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
    Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cosmetic outcome on quality of life after breast cancer surgery.
    Kim MK; Kim T; Moon HG; Jin US; Kim K; Kim J; Lee JW; Kim J; Lee E; Yoo TK; Noh DY; Minn KW; Han W
    Eur J Surg Oncol; 2015 Mar; 41(3):426-32. PubMed ID: 25578249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of quality of life of Turkish breast cancer patients receiving breast conserving surgery or modified radical mastectomy.
    Acil H; Cavdar I
    Asian Pac J Cancer Prev; 2014; 15(13):5377-81. PubMed ID: 25041005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EORTC QLQ-ELD14 questionnaire for elderly cancer patients. Validation study for elderly Spanish breast cancer patients.
    Arraras JI; Asin G; Illarramendi JJ; Manterola A; Salgado E; Dominguez MA
    Rev Esp Geriatr Gerontol; 2019; 54(6):321-328. PubMed ID: 31266659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
    Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
    Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
    Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
    Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.
    Winters ZE; Balta V; Thomson HJ; Brandberg Y; Oberguggenberger A; Sinove Y; Unukovych D; Nava M; Sandelin K; Johansson H; ; Dobbeleir J; Blondeel P; Bruno N; Catanuto G; Llewellyn-Bennett R
    Br J Surg; 2014 Mar; 101(4):371-82. PubMed ID: 24474151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.